Treatment of Medullary Thyroid Cancer with Bone Metastasis

Medullary thyroid carcinoma (MTC) presenting with bone metastases requires a structured, complication-specific approach. Skeletal involvement can drive pain, fracture risk, and, in severe cases, urgent neurological compromise — each with distinct management considerations.

Clinical Scenario

This protocol targets patients with medullary thyroid carcinoma and bone metastases. The management of these patients encompasses strategies directed at painful osseous lesions and structural skeletal complications, including vertebroplasty, surgical excision, thermoablation, cement injection, and external beam radiotherapy, depending on the presentation.

Treatment Approach

For painful osseous metastases, bone-targeting systemic agents are a recommended cornerstone of care. Where structural complications arise, multiple local interventional strategies are available — the appropriate choice depends on the specific complication type and patient candidacy.

The full structured regimen — including specific agents, decision criteria for each complication scenario, and sequencing — is available in the complete protocol.